Search - tctmd.com

Displaying 1 - 20 of 46

Sort: Relevancy | Date

BEAT PAROX-AF: Pulsed-Field Ablation Not Superior to Radiofrequency

News Conference News ESC 2025

BEAT PAROX-AF: Pulsed-Field Ablation Not Superior to Radiofrequency

September 09, 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

News Conference News ESC 2025

Olezarsen Brings Moderately High Triglycerides Under Control: ESSENCE-TIMI 73b

August 31, 2025

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

News Conference News ESC 2025

BaxHTN: Baxdrostat Lowers BP in Uncontrolled and Resistant Hypertension

August 31, 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

News Conference News ESC 2025

Digitoxin Cuts Risk in Well-Treated HFrEF Patients: DIGIT-HF

Michael O'Riordan

August 29, 2025

Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias

News Conference News ESC 2025

Boosting Potassium Helps Patients at High Risk for Ventricular Arrhythmias

August 29, 2025

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

News Conference News ESC 2024

MitraClip vs Surgery for Severe FMR? MATTERHORN Claims Noninferiority

September 01, 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

News Conference News ESC 2024

FINEARTS-HF: Benefit of Finerenone Extends to HFmrEF and HFpEF Patients

Michael O'Riordan

September 01, 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

News Conference News ESC 2024

RESHAPE-HF2 Is a Win for MitraClip in FMR—Not Everyone’s On Board

August 31, 2024

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

News Conference News ESC 2023

ESC Focused Update on HF Synthesizes New Trial Data for Practical Use

September 01, 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

News Conference News ESC 2023

ORION-8: Safe and Durable Longer-Term LDL-Lowering With Inclisiran

Michael O'Riordan

September 01, 2023

ESC Endocarditis Guidelines Get First Update in 8 Years

News Conference News ESC 2023

ESC Endocarditis Guidelines Get First Update in 8 Years

August 31, 2023

ESC Cardiomyopathy Guidelines Span Range of Phenotypes

News Conference News ESC 2023

ESC Cardiomyopathy Guidelines Span Range of Phenotypes

Yael L. Maxwell

August 31, 2023

CASTLE-HTx: AF Ablation Boosts Outcomes in Advanced Heart Failure

News Conference News ESC 2023

CASTLE-HTx: AF Ablation Boosts Outcomes in Advanced Heart Failure

August 28, 2023

ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems

News Conference News ESC 2023

ADVENT: Pulsed-Field Ablation for Paroxysmal AF Performs Well vs Thermal Systems

August 27, 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

News Conference News ESC 2022

New ESC/ERS Pulmonary Hypertension Guidelines Urge Precise Diagnosis, Early Treatment

September 01, 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

August 29, 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

News Conference News ESC 2022

Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke

August 28, 2022

No Hints of Cognitive Defects With ARNIs in HFpEF

News Conference News ESC 2022

No Hints of Cognitive Defects With ARNIs in HFpEF: PERSPECTIVE

August 26, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.